{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The test-compound concentrations, LASSBio 772, for obtaining competition curves varied from 3 pM to 100 nM.\n* The rat tissues (salivary gland, liver) after homogenization, centrifugation, re-suspension and re-centrifugation, were incubated with [<sup>3</sup>HJprazosin (0.06 nM), in 60 mM Tris-HCI (pH 7,5) buffer \n* The preparation was submitted to contraction with phenylephrine (5 x 10<sup>\"5</sup> M) and, then the rings were washed to reach the basal line (0% of vasoconstriction).\n* A curve, using increasing concentrations of phenylephrine (5x10<sup>\"9</sup> - 5x10<sup>\"</sup> M), was performed for each ring, as a positive control."}
{"final_json": [{"molecule_name": "LASSBio 772", "protein_target_name": null, "binding_metric": null, "value": "3 pM to 100 nM", "unit": null}, {"molecule_name": "[<sup>3</sup>H]prazosin", "protein_target_name": null, "binding_metric": null, "value": "0.06", "unit": "nM"}, {"molecule_name": "phenylephrine", "protein_target_name": null, "binding_metric": null, "value": "5 x 10^5", "unit": "M"}, {"molecule_name": "phenylephrine", "protein_target_name": null, "binding_metric": null, "value": "5x10^9 - 5x10^", "unit": "M"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "0", "unit": "%"}]}
{"raw_mentions": "Here are the extracted sentences:\n\nHowever, the evaluation of this compound in comparison to the contractions induced by histamine (100 microM), Hi receptors agonist, the compound LASSBio 772 (3 nM - 30 microM), was able to significantly inhibit contractions, showing an IC50 = 309 nM (IC50 = concentration able to inhibit 50% of the effect).\nBesides the observed effect in comparison to Hi receptors, it is valid to stress that alpha-adrenergic antagonist evaluation yielded an IC50 0,26 nM, while its Hi anti-histaminergic effect yielded an IC50 309 nM, that gives a selectivity ratio of about 1000 times for the alpha-adrenergic antagonist effect in relation to the H1 antagonist effect.\nThe preliminary results demonstrated high affinity of LASSBio 772 for the prostatic tissue with antagonist potency, pKB 9.30 (0.5 nM), corroborating its potential use as an antagonist for the prostatic obstruc \nIn this experiment the compound was evaluated for its capability to inhibit the relaxation produced by salbutamol (10\u00b0 - 3,3 x10\u00b05 M), beta 2 adrenergic agonist, in strips of cobaio trachea pre-contracted with carbacol (10 microM)."}
{"final_json": [{"molecule_name": "LASSBio 772", "protein_target_name": "Hi receptors", "binding_metric": "IC50", "value": "309", "unit": "nM"}, {"molecule_name": "LASSBio 772", "protein_target_name": "alpha-adrenergic", "binding_metric": "IC50", "value": "0,26", "unit": "nM"}, {"molecule_name": "LASSBio 772", "protein_target_name": "Hi receptors", "binding_metric": "IC50", "value": "309", "unit": "nM"}, {"molecule_name": "LASSBio 772", "protein_target_name": null, "binding_metric": "pKB", "value": "9.30", "unit": null}, {"molecule_name": "salbutamol", "protein_target_name": "beta 2 adrenergic", "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "carbacol", "protein_target_name": null, "binding_metric": null, "value": "10", "unit": "microM"}, {"molecule_name": "histamine", "protein_target_name": null, "binding_metric": null, "value": "100", "unit": "microM"}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nRabbit aorta - \u03b1 > CCIB Prazosin 9,05 1,02 [0,95-1,10] > 20 \nRat aorta - \u03b1D Prazosin 9,77 0,17 [9,65-9,88] 3 \nLASSBio 772 7,85 14,12 18 \nBMY7378 8,22 6,025 - - \nLASSBio 772 10,86 0,014 [10,33-11,39] 10 \nLASSBio 772B 10,70 0,020 [10,52-10,88] 3 \nHuman Prostate - \u03b11A LASSBio 772 9.3/0.5 - 2 \nRat salivary gland - \u03b11A LASSBio 772 0,26 0,14 2 \nRabbit liver - \u03b11A LASSBio 772 4,9 4,00-5,00 3 \nLASSBio 772B 23,9 19,00-29,00 3 \nRat liver - 1B LASSBio 772 450,00 - [140-1380] 3 \nLASSBio 772B 130,00 - [100-180] 3"}
{"final_json": [{"molecule_name": "Prazosin", "protein_target_name": "\u03b1", "binding_metric": null, "value": "> 20", "unit": null}, {"molecule_name": "Prazosin", "protein_target_name": "\u03b1D", "binding_metric": null, "value": "3", "unit": null}, {"molecule_name": "LASSBio 772", "protein_target_name": null, "binding_metric": null, "value": "18", "unit": null}, {"molecule_name": "BMY7378", "protein_target_name": null, "binding_metric": null, "value": "-", "unit": null}, {"molecule_name": "LASSBio 772", "protein_target_name": null, "binding_metric": null, "value": "10", "unit": null}, {"molecule_name": "LASSBio 772B", "protein_target_name": null, "binding_metric": null, "value": "3", "unit": null}, {"molecule_name": "LASSBio 772", "protein_target_name": "\u03b11A", "binding_metric": null, "value": "2", "unit": null}, {"molecule_name": "LASSBio 772", "protein_target_name": "\u03b11A", "binding_metric": null, "value": "2", "unit": null}, {"molecule_name": "LASSBio 772", "protein_target_name": "\u03b11A", "binding_metric": null, "value": "3", "unit": null}, {"molecule_name": "LASSBio 772B", "protein_target_name": null, "binding_metric": null, "value": "3", "unit": null}, {"molecule_name": "LASSBio 772", "protein_target_name": "1B", "binding_metric": null, "value": "3", "unit": null}, {"molecule_name": "LASSBio 772B", "protein_target_name": null, "binding_metric": null, "value": "3", "unit": null}]}
